Amit Roy

12PUBLICATIONS
29CO-AUTHORS
Toxicology (incl. clinical toxicology)Radiation therapyPharmacogenomicsCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 24, 2025
Model-Informed Drug Development of Subcutaneous Nivolumab: Comparison of Pharmacokinetic Analysis Methodologies Using Clinical Trial Simulation.

Yue Zhao, Heather Vezina, Zheyi Hu

|Aug 18, 2025
Exposure-Response Analysis of Repotrectinib to Support the Dose Recommendation for Patients With ROS1-Positive NSCLC or NTRK-Positive Solid Tumors.

Shengnan Du, Zheyi Hu, Jun Shen

|Aug 13, 2024
Characterization of mavacamten pharmacokinetics in patients with hypertrophic cardiomyopathy to inform dose titration.

Peter Chang, Vidya Perera, David H Salinger

|May 02, 2024
Recommendation of mavacamten posology by model-based analyses in adults with obstructive hypertrophic cardiomyopathy.

Samira Merali, David H Salinger, Maria Palmisano

|Jan 31, 2024
Model-Informed Clinical Pharmacology Profile of a Novel Fixed-Dose Combination of Nivolumab and Relatlimab in Adult and Adolescent Patients with Solid Tumors.

Yue Zhao, Zheyi Hu, Sai Praneeth Bathena

|Dec 20, 2023
Nivolumab and ipilimumab population pharmacokinetics in support of pediatric dose recommendations-Going beyond the body-size effect.

Zheyi Hu, Sihang Liu, Yue Zhao

Pageof 2

Frequent Collaborators

5 joint publications

Yue Zhao

2 joint publications

Neelima Thanneer

2 joint publications

Anna Kondic

2 joint publications

Vidya Perera